INDBInternet News Database 2.5 Updated just now · 393 sources Show or hide images Light or dark

Sanofi is weighing a takeover bid for U.S. respiratory drugmaker Insmed

Save Like Comments Compare coverage
Image from Quartz

Summary

Insmed stock rose as much as 24% on Thursday, and any deal could be weeks away, according to Bloomberg

Description from Quartz.

Who is covering this

  1. Quartz Leans left Factuality: High US
    Sanofi is weighing a takeover bid for U.S. respiratory drugmaker Insmed

    Insmed stock rose as much as 24% on Thursday, and any deal could be weeks away, according to Bloomberg

Comments

Comments need JavaScript.